StonvexLoading…
StonvexStonvexStonvexCore line items from EVRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.71B | $5.70B | $5.35B | $5.59B |
Operating Income | $1.53B | $1.47B | $1.28B | $1.27B |
Net Income | $855.60M | $873.50M | $731.30M | $752.70M |
EPS (Diluted) | $3.66 | $3.79 | $3.17 | $3.27 |
Total Assets | $33.95B | $32.28B | $30.98B | $29.49B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $19.80M | $22.00M | $27.70M | $25.20M |
Free Cash Flow OCF − CapEx | $-751.70M | $-352.90M | $-353.80M | $-364.60M |
Shares Outstanding | 233.60M | 230.60M | 230.50M | 230.30M |